This Biotech Company Is Using AI to Develop Better Treatments

Evogene (EVGN) is an Israeli computational biology company.

Evogene primarily develops platforms for the biotechnology industry that use big data, advanced algorithms, and artificial intelligence (“AI”) to better observe microbes, molecules, and genetic elements. 

The company’s platform is most commonly used for product development in the plant, cancer, and cannabis markets. It helps increase the success of life-science products by increasing efficacy. 

However, it also enables researchers to cut down on the toxicity of certain ingredients in supplements and medications. Its computational predictive biology platform assists in reducing the time and cost spent on development as well. 

While EVGN is still a relatively young company, it has gained the attention of larger players in the space. Corteva, Bayer, and ICL Group are all strategic partners of the company. 

And it’s no surprise why. In EVGN’s most recent quarter, the company noted positive progress within three of its subsidiary operations. 

EVGN highlighted that pre-clinical data for its microbiome therapeutic candidate in immuno-oncology saw a 50% response rate in reducing tumor activity in a breast cancer model.

The company added that it also reached distribution agreements for the commercialization of cannabis products in Israel in 2022. 

Meanwhile, EVGN said it made major progress in collaboration with Corteva on novel herbicides. The company said testing results showed the company can create herbicides that target specific weeds without hurting crops.

So, given EVGN continues to report positive data, this momentum could help provide a boost to the penny stock’s shares moving forward. 

September 21st will spark the largest wealth transfer in 21 years…

Sponsored: True Market Insiders

If you have even a dollar invested in the stock market, you won’t want to miss this Wall Street legend's critical warning..


According to him, one private D.C. meeting set to take place on September 21st will create the largest wealth transfer in the last 21 years…

Chris Rowe, who became famous for buying Microsoft back in 1996… BEFORE shares skyrocketed 4,850% and Amazon in 1998… before it’s price exploded 29,075%… says:

“Last time something like this happened was over 20 years ago… but one private meeting set to take place on September 21st in Washington D.C. will widen the wealth gap unlike any other time in history.”

If you want to set yourself up to be on the right side of this event…

Chris recently recorded an emergency presentation where he reveals everything that’s happening, and exactly the steps to take immediately.

Including the #1 investment you should make today, completely free, no questions asked.

Click here to view his video before we take it offline.

$3 EV Play No One's Talking About

This company is a sneaky EV play that no one’s talking about. They’re producing an odd variation on the traditional EV that has consumers raving.

Enter your email address to receive this company’s name and ticker symbol for free.


Free Bonus E-Book: The Second Wave Why popular tech stocks could be in store for a 92% meltdown and the #1 investment billionaires are turning to now... from Morning Bullets. Privacy Policy

By submitting your email address, you give Stock Market Junkie permission to 1. deliver the report or research you're requesting to your email inbox, 2. send free ongoing updates via our independent financial email newsletter, and 3. share carefully selected marketing offers for product and services we think will interest you. Your privacy and security are paramount to us. You can unsubscribe at any time. To review our privacy policy, click here: Privacy Policy | How it Works

$30 Stock Freaking Out Billionaires

This stock is an industry leader in a robotics technology that is freaking out billionaires (trading for just $30).

Enter your email address to receive this company’s name and ticker symbol for free.


Free Bonus E-Book: The Second Wave Why popular tech stocks could be in store for a 92% meltdown and the #1 investment billionaires are turning to now... from Morning Bullets. Privacy Policy

By submitting your email address, you give Stock Market Junkie permission to 1. deliver the report or research you're requesting to your email inbox, 2. send free ongoing updates via our independent financial email newsletter, and 3. share carefully selected marketing offers for product and services we think will interest you. Your privacy and security are paramount to us. You can unsubscribe at any time. To review our privacy policy, click here: Privacy Policy | How it Works

The Best TaaS Stock Right Now

This company is set to corner the market in a self-driving technology that  could fundamentally change our entire society – much like the internet did.

Enter your email address to receive this company’s name and ticker symbol for free.


Free Bonus E-Book: The Second Wave Why popular tech stocks could be in store for a 92% meltdown and the #1 investment billionaires are turning to now... from Morning Bullets. Privacy Policy

By submitting your email address, you give Stock Market Junkie permission to 1. deliver the report or research you're requesting to your email inbox, 2. send free ongoing updates via our independent financial email newsletter, and 3. share carefully selected marketing offers for product and services we think will interest you. Your privacy and security are paramount to us. You can unsubscribe at any time. To review our privacy policy, click here: Privacy Policy | How it Works

Up to 20,000 IPOs All in One Day

A radical $2.1 quadrillion shift is coming to the financial markets.

Some are calling it G.T.E. and Mark Cuban, Elon Musk, Richard Branson, and even banks like J.P. Morgan are invested in the tech behind it.

Just $25 could get you in alongside these billionaires. 

Enter your email address to receive the video that reveals it all.


Free Bonus E-Book: The Second Wave Why popular tech stocks could be in store for a 92% meltdown and the #1 investment billionaires are turning to now... from Morning Bullets. Privacy Policy

By submitting your email address, you give Stock Market Junkie permission to 1. deliver the report or research you're requesting to your email inbox, 2. send free ongoing updates via our independent financial email newsletter, and 3. share carefully selected marketing offers for product and services we think will interest you. Your privacy and security are paramount to us. You can unsubscribe at any time. To review our privacy policy, click here: Privacy Policy | How it Works

$2 Biotech Stock

Steve Cohen, the billionaire stock picker known for running one of the most successful hedge funds ever, has poured millions into the first stock, and it’s trading for only $2.

Enter your email address to receive this company’s name and ticker symbol for free.


Free Bonus E-Book: The Second Wave Why popular tech stocks could be in store for a 92% meltdown and the #1 investment billionaires are turning to now... from Morning Bullets. Privacy Policy

By submitting your email address, you give Stock Market Junkie permission to 1. deliver the report or research you're requesting to your email inbox, 2. send free ongoing updates via our independent financial email newsletter, and 3. share carefully selected marketing offers for product and services we think will interest you. Your privacy and security are paramount to us. You can unsubscribe at any time. To review our privacy policy, click here: Privacy Policy | How it Works